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ABSTRACT 
Multiple particle tracking (MPT) methodology was used to dissect the impact of nanoparticle 
surface charge and size upon particle diffusion through freshly harvested porcine jejunum 
mucus.  The mucus was characterised rheologically and by atomic force microscopy. To vary 
nanoparticle surface charge we used a series of self-assembly polyelectrolyte particles 
composed of varying ratios of the negatively charged polyacrylic acid polymer and the 
positively charged chitosan polymer. This series included a  neutral or near-neutral particle  
to correspond to highly charged but near-neutral viral particles that appear to effectively 
permeate mucus.  In order to negate the confounding issue of  self-aggregation of such 
neutral synthetic particles a sonication step effectively reduced particle size (to less than 340 
nm) for a sufficient period to conduct the tracking experiments.  Across the polyelectrolyte 
particles a broad and meaningful relationship was observed between particle diffusion in 
mucus (x1000 difference between slowest and fastest particle types), particle size (104 nm to 
373 nm) and particle surface charge (-29 mV to + 19.5 mV),   where the beneficial 
characteristic promoting diffusion was a neutral or near-neutral charge. The diffusion of the 
neutral polyelectrolyte particle (0.02887 cm2.S-1 x10-9) compared favourably with that of a 
highly diffusive PEGylated-PLGA particle (0.03182 cm2.S-1 x10-9), despite the size of the 
latter (54 nm diameter) accommodating a reduced steric hindrance with the mucin network. 
Heterogeneity of particle diffusion within a given particle type revealed the most diffusive 
10% sub-population for the neutral polyelectrolyte formulation  (5.809 cm2.S-1 x10-9) be 
faster than that of the most diffusive 10% sub-populations obtained for either the PEGylated-
PLGA particle  (4.061 cm2.S-1 x10-9)  or for a capsid adenovirus particle (1.922 cm2.S-1 x10-
9).  While this study has used a simple self-assembly polyelectrolyte system it has 
substantiated the pursuance of other polymer synthesis approaches (such as living free-radical 
polymerisation) to deliver stable, size-controlled nanoparticles possessing a uniform high 
density charge distribution yielding net neutral surface potential. Such particles that will 
provide an additional strategy to that of PEGylated systems where the interactions of 
mucosally-delivered nanoparticles with the mucus barrier are to be minimised.  
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INTRODUCTION 
Safeguarding the stability and effective delivery of biopharmaceuticals within the gastro-
intestinal (GIT) lumen is addressed in a number of ways the most usual of which is the 
formulation of the therapeutic into a protective nanoparticle (NP).  Such NPs which may 
release cargo in close proximity to the absorption barrier or, as a fully intact particle, be 
transported across the epithelium [1].  Irrespective of the overall strategy the permeation of 
NPs through the extracellular covering of mucus  to reach the underlying epithelial surface is 
recognised as a significant limitation [2]. 
The mucus barrier comprises a firmly adherent unstirred viscous layer directly adjacent to the 
epithelium, and a loosely adherent less viscous layer more distal to the epithelium. The main 
constituents of mucus are: mucin glycoproteins, lipids, and sloughed cellular material. It is 
the high molecular weight mucin glycoprotein that is the main component restricting the 
movement of particles. Specifically,  particle permeation through the mucus gel is recognised 
to be affected by several types of interactions, including: contact of the particle with the 
hydrophobic domains of the mucin polymer; steric hindrance physically restricting particle 
movement through the porous water-filled channels of the mucus gel network [3]; cohesive 
and repulsive electrostatic contacts of the particle with, in particular, the dense coat of 
glycans covering the mucin fibre which display charged sulphate or carboxylate groups [4,5].   
The concept of modifying a particle‟s  surface characteristics to enhance permeation through 
mucus was first described by  Lai et al [6], and has most commonly  involved  the generation 
of a  polar particle surface by various PEGylation strategies. For example, Hanes‟ group [7] 
has shown that while particle size per se has some role in determining mucus permeation it is 
the particle‟s surface characteristics that can have a more profound impact, e.g. PEGylation 
of a 500 nm polystyrene particle increasing permeation by >1000-fold. In contrast to 
synthetic particles, some viral particles are well adapted for efficient mucus gel permeation,  
for example, the Norwalk virus (38 nm) and human Papilloma virus (55nm) appear to 
penetrate mucus in an unrestricted manner [8]. The general features enabling the permeation 
of such viruses appear to be their small size, the lack of a hydrophobic envelope, and the 
possession of an exposed hydrophilic protein capsid shell characterised by a  high surface 
density of +/- charges giving a net membrane potential close to neutrality [8,9]. However, the 
ability to mimic the surface characteristics of a virus is a challenge when constructing 
synthetic particles not least, because of the tendency toward particle aggregation as surface 
charge approaches neutrality.   Nevertheless, there is some evidence that a synthetic particle 
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of near-neutral surface charge (+0.9 mV), and comprising polyacrylic acid (PAA; -ve) and 
polyallylamine (PAM; +ve) polymers, does show improved mucus permeation, at least in an 
in-vitro side-by-side diffusion chamber model [10]. The approach of  generating a polar, 
electrically neutral surface on a synthetic particle has been described as mediating a particle‟s  
‟slip‟ through mucus [11]. 
Using multiple particle tracking (MPT) methodology this current work explored the impact 
upon NP diffusional kinetics through mucus of the variables of particle surface charge and 
size. Polyelectrolyte NPs of various surface charge were formulated by combining different 
ratios of PAA (-ve) and chitosan (+ve) polymers. The study used freshly harvested and 
characterised (rheologically and by surface morphology) porcine jejunum intestinal mucus. In 
particular we sought to examine the diffusion of a synthetic particle possessing a charged but 
electrically neutral surface. To address the tendency of neutral polyelectrolyte particles to 
self-aggregate we adopted a sonication step that effectively reduced the size of large neutral 
particles for a sufficient period to conduct MPT.  To account for the impact of a particle‟s 
size upon its unrestricted diffusion in solution we referenced the particle diffusion data in 
mucus to the respective data in water. Beyond diffusion coefficients per se we report on the 
proportion of diffusive particles in each formulation, and the heterogeneity of diffusion 
within sub-populations of a given particle type.  Comparison was also made to a non-charged 
hydrophilic particle, PLGA-PEG, and to a capsid virus with a near neutral surface charge. 
Even for the simple polyelectrolyte systems we found neutral or near-neutral charged 
particles to display a significant advantage in terms of diffusion in mucus.  This finding 
substantiates the pursuance of other polymer synthesis approaches ultimately yielding stable 
particles with a high charge density but net neutral surface potential that will provide minimal 
particle interactions with the mucus barrier.  
MATERIALS AND METHODS 
Materials 
The chitosan polymer (low MW), polyacrylic acid (PAA) polymer (MW 1800) and MES 
buffer were obtained from Sigma-Aldrich (UK).  PLGA (PDLG-5002 containing 
lactic:glycolic at 50%:50%,  MW 17 KDa.) and  PEGylated-PLGA  (mPEG  MW 5 KDa. at 
85%PLGA: 15% mPEG) and Lumogen Red-305 (LR) (excitation 573 nm emission 612 nm) 
were all supplied by Nanomi (Netherlands). The amplified AD5 virus was kindly provided by 
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the Institute of Cancer Genetics (Cardiff University).  Alexa Fluor® 488 Protein labelling kit 
was from Life Technologies (UK). Glass bottom imaging dishes (35 mm diameter dish with a 
glass coverslip at 1.5 mm thick and 10mm diameter) were from MatTek Corporation (USA). 
All other reagents and solvents were from Fisher Scientific (Loughborough, UK). 
Mucus 
Freshly isolated  pig intestinal ileum (2 m in length from proximal region)  was obtained from 
a local  abattoir (Cardiff) and kept in ice-cold oxygenated phosphate buffered saline (PBS) 
(no longer than 2 hrs) prior to sample processing. The ileum was processed into 25 cm 
lengths with each length incised longitudinally to allow intestinal food and other waste debris 
to be was gently rinsed away by ice-cold PBS. The mucus was then harvested by an approach 
[2] recognised to optimise the yield of not only the loose mucus layer but  critically also a
high content of the adherent mucus layer.  Simply it involved gentle scraping from the 
intestinal surface by spatula avoiding the shedding of significant intestinal epithelial tissue. 
Mucus was divided into aliquots (0.5 g) and kept at -20 °C  prior to  experimentation [12] 
Methods 
Nanoparticle preparation 
Polyelectrolyte NPs were prepared from chitosan and polyacrylic acid (PAA) polymers 
which respectively served as the source for the positive and negative charges.  Stock 
solutions (1% w/v) of chitosan and PAA were prepared in 1% glacial acetic acid and in 
distilled deionised (DD) water, respectively. Working solutions for both polymers were 
prepared by diluting the stock solutions to 0.02% w/v with MES buffer pH 6.5.  The 
polyelectrolyte NPs were synthesized by the self-assembly technique [13] whereby the dilute 
solution of chitosan was added drop wise (1 drop/minute) to the dilute solution of PAA and 
the mixture stirred magnetically for 16 hrs. The use of MES buffer in the NP self-assembly 
process avoided precipitation issues evident when phosphate or citrate buffers were used.   
Lumogen Red-305  (LR) was loaded into the NPs by the coacervation technique [14], 
whereby LR  dissolved (0.2 % w/v) in acetone was  added to the dilute solution of  PAA prior 
to the addition of chitosan.  The mass of LR added equated to 150 g LR per 30 mg of 
combined PAA:chitosan polymer.  The acetone was evaporated during the mixing allowing 
LR loading to the core of the polyelectrolyte NPs. All particles were subject to a  2 hr 
stability test for size and zeta-potential (see below) prior to capture of multiple particle 
tracking data. 
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Nanoparticle sonication 
Polyelectrolyte NPs displaying a neutral surface charge (i.e. PAA:chitosan mass ratios of 1: 
2.2) gave rise to large particles.  Given a key aim of the study to investigate the relative 
significance of charge and size as independent variables, these large neutral particles were 
temporarily reduced in size by probe sonication. Accordingly, suspensions of the neutral NPs 
(ca 1200 nm) were sonicated (Fisher scientific probe sonicator, UK) for 2 min. at 20 KHz and 
70% amplitude with the suspension then syringe-filtered through 0.45µ membrane 
(Millipore, UK)   Particle size and zeta potential were measured immediately after filtration 
and over a subsequent test period (2 hr) to ensure a sufficient duration of size stability to 
enable the conduct of the mucus diffusion studies. To serve as controls for the sonication 
process both  positively-charged (i.e. PAA:chitosan mass ratio of  1 : 8) and  negatively-
charged (i.e. PAA:chitosan mass ratio of  1 : 1) polyelectrolyte NPs were also subject to the 
sonication process and their diffusion characteristics (before and after) were determined.  
Zeta potential measurement 
A Malvern NANO ZS (Malvern, UK) was used to measure the zeta potential of the NP 
samples. The instrument was standardised prior to each experiment by use of calibration 
standards.  
Particle size measurement 
Particle size (diameter) was measured by photon correlation spectroscopy (Malvern NANO 
ZS) with data collected in uni-modal setting. The instrument was standardised prior to each 
experiment by use of calibration standards.  
Rheological studies on mucus 
The measurement of the elastic modulus (Storage) and the viscous modulus (Loss) was 
undertaken using an IR550 rheometer (TA Instruments, USA) (University Ramon Llull, 
Barcelona, Spain).  The strain sweep test was conducted using 40 mm diameter parallel plates 
with a gap width of 1 mm. An oscillating amplitude mode was applied at up to 95% strain in 
which the plateau stress curve is obtained and the Loss (G´´) and Storage (G´) modulus 
recorded in Pascal. The phase angle (δ) was calculated by the equation: tan δ= (G´´/ G´) [15].  
Atomic Force Microscopy (AFM) imaging of mucus 
7 
AFM imaging (XE-100 Advanced Scanning Probe Microscope, Park Systems, Korea) was 
used to assess the surface morphology of the pores in the mucus network. Samples were 
scanned at a large format of 25x25 µm then zoomed to 15x15 µm and 5x5 µm formats. For 
each format 10 images were acquired at random locations. From each image the diameters of 
all visible pores were measured and the overall distribution of pore diameters assessed.  
Multiple particle tracking (MPT) in mucus 
NP diffusion  through intestinal mucus was assessed by MPT technique using previously 
described mathematical approaches  [6,7,16,17]. Samples (0.5 g) of porcine intestinal mucus 
were incubated in glass-bottom MatTek imaging dishes at 37 °C.  The fluorescently labelled 
NPs were inoculated into each 0.5 g mucus sample in a 25 µl aliquot at a suspension 
concentration of 0.002% NPs, a dilution confirmed to reproducibly avoid particle aggregation 
at the point of inoculation into the mucus sample. To ensure effective particle distribution 
following inoculation within the mucus a 2 hr period of equilibration was adopted prior to 
beginning video microscopy capture of NP movements. Video capture  involved 2-
dimensional imaging on a  Leica DM IRB wide-field epifluorescence microscope (x63 
magnification oil immersion lens) using a high speed camera  (Allied Vision Technologies, 
UK) running at a frame rate of  33 ms i.e. capturing 30 frames sec-1 ;  each completed video 
film comprised 300 frames. For each 0.5 g mucus sample approximately 120 NPs were 
simultaneously tracked and their movements captured. For any distinct NP species, e.g. a 
particular polyelectrolyte mass ratio, a minimum of three distinct mucus samples were 
analysed, i.e. minimum of 360 individual NP trajectories assessed.  
The tracking (over  a maximum of 10 seconds) of fully intact discrete particles was defined 
by microscopic criteria, and particle size and zeta potential stability over 2 hr. (see above); 
any fluorescent dye dissociated from the surface of the particle contributed only to the 
background fluorescence and not to the appearance of  distinct microscopic particles. 
Supplementary videos 1, 2 and 3 show respectively the video capture of the 334 nm diameter 
polyelectrolyte neutral particles, i.e.  [F8] formulation, the 54 nm PEG-PLGA particles and 
the 146 nm AD5 capsid virus.   
Videos were imported into Fiji ImageJ software to convert the movement of each NP into 
individual NP trajectories across the full duration of the 10 sec. videos.  However, for the 
analysis of particle diffusion only a 30 frame video period (1 sec) was used, with the criterion 
that any individual particle tracked must  display a continuous presence in the X-Y plane 
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throughout the respective 30 sequential frames.  Limiting the period of analysis to 30 frames 
minimised the impact of mucin movement upon the particle diffusion calculations [6]. The 
individual particle trajectories were converted into numeric pixel data (Mosaic Particle 
Tracker within Fiji ImageJ) which, based on the microscope and video capture settings, was 
converted into metric distance. The distances moved by every individual particle over a 
selected time interval (Δt) in the X-Y trajectory were then expressed as a squared 
displacement (SD). The mean square displacement (MSD) of any single particle (n) 
represents the geometric mean of that particle‟s squared displacements throughout its entire 
30-frame trajectory.
MSD was determined  as follows [18]: 
MSD(n)  = (XΔt)2 + (YΔt)2     Equation 1  
In any single mucus sample experiment an MSD was calculated for at least each of 120 
individual particles (i.e. 120 MSD calculations)  with the experiment replicated a further two 
times for any particle type, i.e. at least 360 particles studied in total. For each NP type under 
study (e.g. PEG-PLGA) an “ensemble mean square displacement” (defined by <MSD>) was 
then determined for each of the three replicate studies.  The Effective Diffusion Coefficient 
(<Deff>) for a particular NP type was then calculated by: 
<Deff> = <MSD>/ (4 * Δt)         Equation 2 
Where 4 is a constant relating to the 2-dimensional mode of video capture and Δt is the 
selected time interval. 
Proportion of diffusive particles:  Measuring particle  diffusion across various time intervals 
allows for a description of the proportion of particles that are diffusive through the mucus 
matrix [6].  
Equation 3 was used to determine a Diffusivity Factor (DF) which expresses the effective 
diffusion coefficient for each individual particle (Deff) across the time intervals (Δt) of 1 sec. 
and 0.2 sec.  
DF = Deff Δt=1 sec / Deff Δt=0.2 sec         Equation 3 
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Where the individual particle Deff = MSD/ (4 * Δt).   Particles with a DF value of 0.9 and 
greater were defined as diffusive.   The proportion of the diffusive particles within a given 
NP type under study was then calculated and expressed as %Diffusive particles. 
Heterogeneity in particle diffusion:  Profiling the diffusive properties of each particle within 
an entire population provides information on the heterogeneity of particle movement and the 
presence of outlier sub-populations that may follow distinct pathways of diffusion through 
the matrix.    Here the effective diffusion coefficient for each individual particle (Deff) was 
calculated at the time interval (Δt) of 1 sec, and for any NP type all 360 Deff Δt=1 sec were then 
ranked to allow comparison of the highest (90th) and lowest (10th) percentiles, where for 
example the 90th percentile is the Deff value below which 90% of the Deff observations may 
be found. 
Particle diffusion in water 
The particles‟ diffusion coefficient (D°) in water was calculated by the Stokes-Einstein 
equation at a temperature of  37 C° [19]:   
[D° = κT / 6πηr]                Equation 4     
Where  is Boltzmann constant, T is absolute temperature, η is water viscosity and r is radius 
of the particle. 
The diffusion of all particles were also expressed as the parameter, %ratio [Deff] / [D°]. 
Statistical analysis 
One-way ANOVA and Bonferonni multiple comparison tests were used for the comparative 
analysis between multiple particle types. A significance level p < 0.05 was applied.  
RESULTS AND DISCUSSION 
Intestinal mucus represents a primary barrier for the access of NP to the enterocyte surface 
where release of therapeutic cargo is ideally triggered. In this work we used MPT 
methodology to explore the NP diffusivity through porcine intestinal mucus and how 
diffusivity was influenced by the variables of particle surface charge and size. To explore the 
impact of these variables we chose to use a series polyelectrolyte NP formulations composed 
of variable ratios of the charged polymers PAA (-ve) and chitosan (+ve).  The model 
provided a simple two component chemistry self-assembly system providing particles of 
10 
variable surface charge.  In particular we sought to determine the comparative effectiveness 
of highly charged but neutral or near-neutral particles to diffuse through mucus.  Our enquiry 
was underpinned by the effectiveness of some viral particles to permeate through mucus not 
only as a result of their small particle dimensions, but also through possession of a highly 
charged near-neutral exterior facing surface. Our multi-variate analysis of polyelectrolyte 
particle diffusion also included comparison to the diffusion kinetics of a capsid virus with a 
near neutral surface charge, and to a non-charged hydrophilic particle, i.e. PLGA-PEG, the 
nature of which has previously been shown to facilitate  high diffusivity in cervico-vaginal 
mucus [6]. Even for the simple polyelectrolyte systems we found neutral or near-neutral 
charged particles to display a significant advantage in terms of diffusion. This finding 
substantiates the pursuance of other polymer synthesis approaches, such as living free radical 
chemistry, to deliver stable, size-controlled nanoparticles possessing a uniform high density 
distribution of positive and negative surface charges to ultimately yield a net neutral surface 
potential. Such particles that will provide an additional strategy to that of PEGylated systems 
when interactions with the mucus barrier are to be minimised.  
Table 1 shows the zeta potential and particle size measurements of the polyelectrolyte NPs 
formulated from the PAA and chitosan polymers. The Effective Diffusion Coefficient 
(<Deff>) in mucus is shown for each NP type, also shown is the respective Diffusion 
Coefficient in water (D°).  Moreover, the ratio (expressed as %) of these two parameters, (% 
ratio <Deff> / D°) provides a measure of the relative efficiency of particle diffusion through 
mucus when the particles‟ intrinsic free Brownian motion in water is taken into account.  As 
such it affords comparison of particle diffusion in mucus after accounting for the impact of a 
particle‟s size upon its unrestricted diffusion in solution.  It is essentially a measure that more 
directly addresses the relative impact between particles of differing surface physico-chemical 
properties and the interactions with, and the steric hindrance of, the mucin network.  
Rheological assessment of the mucus showed it to possess a gel structure defined by a storage 
modulus (G´) that was greater than the loss modulus (G´´) (Supplementary Figure 1.) and a δ 
of less than 45°  [20];  specifically  δ values were recorded  between 14.82 to 16.22°.  
Supplementary Figure 2a shows the surface morphology of the mucus with large (25x25 µm), 
medium (15x15 µm) and small (5x5 µm) field AFM images of the pore characteristics of the 
mucus network.  Supplementary Figure 2b shows a histogram of the size distribution of over 
98% of all AFM visualised pores within the mucus gel across ten randomly selected AFM 
fields each of 25x25 µm.  The mucus harvesting approach that was used is one recognised  to 
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contain both loose and adherent mucus layers [2,21], and consistent with this we found the 
pore population to be comparatively heterogeneous with an approximate 7-fold range in the 
pore size from 60 nm to 400 nm, but with a distribution defined by approximately 50% of the 
pores below 200 nm in diameter  and  33% between 300 to 400 nm. 
The polyelectrolyte NPs possessed a surface charge ranging from -29 mV to +19 mV and a 
hydrodynamic diameter ranging between 104 nm to 373 nm (Table 1). The exception to this 
was the neutrally charged (-0.5 mV) polyelectrolyte particle [F7] which, lacking repulsive 
electrostatic or steric hindrance forces, aggregated to a size of 1244 nm.  While more 
generally there was no obvious pattern between polyelectrolyte particle diameter and <Deff> 
(Figure 1a), it is clear that size had a significant role in restricting the movement of [F7] 
compared to its smaller derivative particle [F8] (+1.1 mV, 334 nm), the latter  displaying an 
approximate 12-fold greater <Deff> (Figure 1b).  The [F8] particle was derived by sonication 
and filtration of [F7] specifically with the aim to provide a neutral particle whose size was 
consistent with the other polyelectrolyte NP formulations. The size stability of [F8] in water 
was confirmed over a time period of 2 hr, sufficient to allow its physical characterisation and 
the conduct of the MPT experiments; the absence of re-aggregation of these particles in 
mucus during the MPT experiment itself was confirmed by fluorescence microscopy. To 
address if the  sonication process may have led to an increase in particle diffusion by 
mechanisms beyond a reduction in particle size per se,  the largest +ve particle,  [F5],  and 
largest -ve particle, [F13], were also subjected to the sonication process;  neither of the 
respective derived particles, [F6] and [F14], showed enhanced diffusion. The more general 
issue of size-dependency in particle diffusion through mucus appears to be more discernible 
for particles of a consistent surface chemistry.  For example, Dawson et al.  [22] using either 
amine or carboxylate terminated polystyrene NPs showed size-dependency (range 100 nm to 
500 nm) in particle diffusion within cystic fibrosis sputum. Similarly, the movement of DNA 
through cervical mucus has been shown to be dependent upon DNA particle diameter in the 
range 115 to 310 nm [23].  Nevertheless, the effect of particle size upon diffusion within 
mucus is just one variable and, depending upon context, the surface properties can potentially 
be more significant.   
The polyelectrolyte particles in the current work displayed zeta-potentials ranging between -
30 mV [F1] to +20 mV [F14] (Table 1). An essentially neutral  zeta potential was obtained at 
a PAA:chitosan mass ratio of 1:2.2 [F7, F8], a mass ratio  consistent with the PAA polymer 
possessing a relatively  higher density of  negatively charged groups compared to the density 
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of positive charges on each chitosan molecule  [24].  Particles less than 365 nm and which 
displayed the greater <Deff> (Figure 1c, Table 1) were those which bore negative (-25 mV 
and greater) (i.e. particles [F3-F6]) or near neutral surface charge (i.e. [F8] and [F9]).  For 
example, the [F5] particle (-15.4 mV) showed an approximate 14-fold greater <Deff> than 
the [F1] particle (-29.1 mV) despite the former being of a larger size (357 nm vs 104 nm).  
Positively charged particles of greater than +14 mV displayed a <Deff> that was at least x10-
fold lower than the neutral [F8] formulation. Generally the positively charged particles 
displayed a much reduced diffusion compared to the negatively charged species.  For the 
positive particles the increasing content of chitosan provides greater opportunity for the NPs 
to interact through electrostatic forces with mucin. However, chitosan interactions with 
mucin are complex, and while electrostatic attraction may be the major mechanism of 
interaction at high chitosan content,  the impact of  progressive charge-shielding of chitosan‟s  
primary amino groups by PAA will reveal significant hydrophobic and H-bonding attractive  
forces For the positive particles the increasing content of chitosan provides greater 
opportunity for mucin to interact through both electrostatic and hydrophobic forces with the 
chitosan polymer  [25,26].The carboxylate groups  of the PAA polymer  will itself provide 
opportunity for H-bonding interactions with mucin [27].   
Figure 2. uses the data from Table 1 to show a 3-dimensional response analysis of 
polyelectrolyte NP diffusion <Deff> through mucus as a function of both particle size and 
zeta potential. The crucial impact of zeta-potential is clear with a „backbone of greatest 
diffusion‟ corresponding with particles of neutral surface charge.   Figure 1E shows the 
relative permeation of the polyelectrolyte particles in mucus expressed as %ratio [Deff]/ [D°] 
and plotted against zeta-potential.  Here, after accounting for the impact of a particle‟s size 
upon its unrestricted diffusion in solution, the superior performance of the neutral ([F8], +1 
mV) is more profound, with this particle displaying a significantly greater (P<0.05) diffusion 
ratio than any other polyelectrolyte formulation.   
By determining the Effective Diffusion Coefficient for each individual particle (Deff) across 
the time intervals of 1 sec.  and 0.2 sec.  we were able to calculate the proportion of the entire 
population of particles that can be defined as diffusive through the mucus [6]. Supplementary 
Figure 3. illustrates individual Deff measurements for 20 randomly selected particles (from 
the neutrally charged sonicated [F8] polyelectrolyte formulation) across the time intervals of 
0.2 sec. and 1 sec. The vast majority of these measurements show a decline in Deff as the 
monitoring interval is extended to 1 sec. compared to the 0.2 sec. interval. This is interpreted 
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as the occurrence with time of increased interactions of a particle with the micro-domains of 
the mucin network. Some particles, however, display a rise in Deff across the 1 sec.  interval 
indicative of free diffusive transport, and it is those particles that display such an increase that 
are taken to represent the proportion of diffusive particles for any particle type, i.e. for [F8] 
the proportion of diffusive particles was 13% (Table 1) and was significantly greater 
(P<0.05) than for all other polyelectrolyte particles despite its greater size of 334 nm. 
Examining particle diffusion over these short time scales substantially eliminates the effect 
that the contractile and stretching behaviour of the mucin fibres themselves may have on 
particle movement [28].  It is noteworthy that the difference in <Deff> between the neutrally 
charged [F7] and [F8] particles (i.e. an approximate x12-fold difference) was directly 
proportional to their respective proportion of Diffusive particles, i.e. 1% to 13%, respectively. 
The PEGylation of particles is aimed at  providing  a uniform uncharged hydrophilic external 
layer that minimises hydrophobic and electrostatic interactions of the particle‟s surface with, 
for example, the hydrophobic  domains or glycosidic linkages of  the mucin fibres [29].  
Indeed  PEGylated NPs have been shown to display high permeation through cervical-vaginal 
mucus [30] and within sputum from cystic fibrosis patients  [31]. Not surprisingly on most 
measures of particle diffusion through mucus we found the PEGylated-PLGA particle was 
superior to any other particle examined. For example, the <Deff> of the PEG-PLGA particle 
was approximately x15-fold greater than that of the neutral [F8] particle (Table 1, Figures 1B, 
1D). Similarly, the proportion of diffusive particles in the PEGylated-PLGA formulation was 
substantially greater (P<0.05) at 32% than for any other particle type examined (Table 1).  
Nevertheless, when accounting for the impact of particle size and unrestricted particle 
diffusion in solution, then the advantage of PEG-PLGA particle over the neutral [F8] 
polyelectrolyte particle is less pronounced, i.e. the %ratio [Deff]/[D°] was only x2.6-fold 
greater (Figure 1F, Table 1), despite the size of the  PEG-PLGA particle (54 nm)  
accommodating a reduced steric hindrance with the mucin network (Figure 1F, Table 1). 
Some capsid virus particles can display  rapid permeation through a mucus gel, e.g. Norwalk 
virus and human papilloma virus [8]. Of importance in this context is the lack of significant 
steric effects facilitated by the virus‟ relatively small geometry (typically <100 nm).  
However,  as  for synthetic particles the electrostatic stability of the virus particle  in 
extracellular conditions is critical [32] and capsid viruses that permeate mucus effectively 
tend to possess an external facing surface that comprises a high density of positive and 
negative charges while presenting an essentially electrically neutral or near-neutral character, 
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i.e. properties that minimising hydrophobic and electrostatic interactions. For example,  
Bozic et al  [33]  analysed the spatial distribution of positive and negative charges across the 
capsid wall of 130 viral capsids and reported the majority to possess an external charge close 
to zero, or slightly negative.  Consistent with this Michen and Graule [34] evaluated the 
isoelectric points (IEP) of  a number of  viruses species, some of which are known to infect 
through intestinal or pulmonary mucus. They reported, for example, the IEP for the Norwalk 
virus to be 5.5 - 6.0, for the Polio virus to be 6.6 -7.4, for the Rotavirus A to approximate 8.0, 
and the Influenza A virus to be 6.5 -7.0.  
In this study we tracked the diffusion of the neutrally charged (-0.5 mV) adenovirus AD5 
particle (size 145 nm) through intestinal mucus. The determined <Deff> of the AD5 particle 
indeed ranked highly, second only to the much smaller  PEG-PLGA particle (54 nm) but only 
some 1.5-fold  greater than the much larger sized neutral polyelectrolyte [F8] formulation 
(334 nm) (Figures 1B and 1D, Table 1).  However,  when accounting for the impact of 
unrestricted particle diffusion in solution, then the neutral polyelectrolyte [F8] particle now 
showed a slightly improved (x1.5 fold greater) mucus permeation over the AD5 particle  
despite the greater size and likelihood of steric hindrance in the mucus (Figure 1F, Table 
1).Clearly, while the AD5 particle displayed a  neutral surface charge other determinants such 
as interaction of the capsid proteins will have likely  impacted, at least in this study, on 
mucus permeation. Indeed glycocalyx and tethered mucin within the respiratory tract have 
been shown to  inhibit adsorption of certain adenovirus serotypes to  lung tissue [35,36].   
The heterogeneity in the movement of individual particles through mucus can provide an 
insight into how different subpopulations within a given formulation (particle) type may 
exploit divergent permeation pathways.  Here we assessed such heterogeneity by measuring 
over a time interval of 1 sec. the effective diffusion coefficient (Deff) for each of 360 
individual particles from any given particle type, and ranking this Deff data into percentiles. 
Figure 3 shows the percentile data for four different particle types.  Generally, the more 
positively or negatively charged the particle type then the less heterogeneous was the 
diffusion data.  For example, for the highly negative (104 nm sized) [F1] formulation some 
90% of the particles displayed a Deff (cm2. S-1 x10-9) below 0.024, while 10% of the particles 
had a Deff below 0.00015 (Figure 3a). The resulting ratio 90th/10th percentile was 150.  For 
the highly positive (373 nm sized) [F14] particle the corresponding ratio was 180 (Figure 3b). 
It is not unreasonable that the more highly charged polyelectrolyte particles will display a 
more homogenous physical character (size, charge), and as such the variability in forces 
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influencing particle diffusion through the mucus will be determined predominantly by the 
structure of the mucus mesh itself rather than any distinct particle subpopulations [22].  
Similarly, the PEG-PLGA particle (54 nm sized) exhibited a 90th/10th percentile ratio of 200 
(Figure 3d), consistent with previously published  PEGylated particle diffusion through 
mucus [6].   In contrast, the sonicated (334 nm sized) neutrally charged [F8] particle 
displayed a marked heterogeneity with a 90th/10th percentile ratio of 11,000 (Figure 3c). This 
is not readily attributable solely to the heterogeneous structure of the mucus mesh but must 
reflect additional diversity involving particle subpopulations and differential forces hindering 
their movement. Creating a charged but neutral synthetic particle through the simple process 
of self-assembly of polyelectrolyte polymers will inevitably lead to opposing surface charges 
that are not uniformly distributed with the result of forming surface „hotspots‟ or surface 
domains of a particular electrical sign that will have differential interactions with the mucin 
network. Indeed, the spatial arrangement of charge on a particle‟s surface, even for particles 
of the same overall net surface charge, has been shown to be influential in particle transport 
through a mucin gel [37]. Such heterogeneity reflects one of the limitations of creating a 
charged but neutral synthetic particle through the simple process of self-assembly of 
polyelectrolyte polymers. Nevertheless, the fastest particles (90th percentile) seen for the 
neutral polyelectrolyte [F8] formulation (i.e. Deff of  5.81; Figure 3c)  were at least as fast as  
the 90th percentile particles  recorded for the much smaller  PEG-PLGA (i.e.  Deff of 4.06; 
Figure 3d).  
In summary, viral particles that possess a highly charged but near-neutral exterior facing 
surface permeate effectively through mucus. As such we sought in this study to determine 
how such properties conveyed to synthetic particles would impact upon their comparative 
diffusion within a mucus matrix.  Using multiple particle tracking methodology we explored 
the impact of surface charge and size upon the diffusion of synthetic particles through freshly 
harvested porcine jejunum mucus.  The principle nanoparticle model was a simple self-
assembly polyelectrolyte system comprising variable ratios of the negatively charged PAA 
polymer and the positively charged chitosan polymer.  To address the tendency of neutral 
polyelectrolyte particles to self-aggregate we adopted a sonication step that effectively 
reduced the size (to less than 340 nm) of the polyelectrolyte neutral particles for a sufficient 
period to conduct the tracking experiments.  Further, by referencing the mucus particle 
diffusion data in mucus to that in water we accounted for the impact of a particle‟s size upon 
its unrestricted diffusion in solution.  The results revealed a broad and meaningful 
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relationship between particle diffusion in mucus (x1000 difference between slowest and 
fastest particle types), particle size (104 nm to 373 nm) and particle surface charge (-29 mV 
to + 19.5 mV).  In particular the crucial impact of zeta-potential was clear, with highest 
diffusion in mucus (from amongst the series of polyelectrolyte particles) observed for those 
of a neutral surface charge (e.g. particle [F8] at +1.1 mV, 334 nm).  The diffusion of the 
neutral polyelectrolyte particle compared favourably with that of a highly diffusive 
PEGylated-PLGA particle (54 nm) despite the size of the latter accommodating a reduced 
steric hindrance with the mucin network. Assessment of the heterogeneity of diffusion within 
a given particle type  revealed the most diffusive neutral polyelectrolyte nanoparticle 
formulation ([F8]) to display a x11,000-fold difference in particle diffusion between the 
fastest 10% sub-population  and the slowest 10% sub-population; a finding likely reflecting a 
non-uniform distribution of surface charge expected for a neutral particle of this type.  Of 
significance the most diffusive 10% sub-population for the neutral polyelectrolyte 
formulation  (5.809 cm2.S-1 x10-9) was faster than the most diffusive 10% sub-populations 
obtained for either the PEGylated-PLGA particle  (4.061 cm2.S-1 x10-9) or for a capsid 
adenovirus particle (1.922 cm2.S-1 x10-9).   While this study has used a simple self-assembly 
polyelectrolyte system to explore the impact of particle size and charge upon mucus 
permeation, it has revealed in a robust manner the clear benefits for a particle possessing a 
neutral or near neutral surface.  Beyond polyelectrolyte systems exploitation of polymer 
synthesis approaches such as living free radical chemistry should deliver stable, size-
controlled nanoparticles possessing a uniform and balanced high density distribution of 
positive and negative surface charges, ultimately yielding particles with a net neutral surface 
potential that will provide an additional strategy to that of PEGylated systems when seeking 
to avoid interactions with the mucus barrier.  
LEGENDS 
Table 1.  Particle physical characteristics and diffusion kinetics in mucus. 
Figure 1: Relationships between particle diameter or zeta potential to particle diffusion 
kinetics in mucus.  (1A) Plot of particle diameter of the polyelectrolyte (PAA:chitosan) NPs 
versus Effective Diffusion Coefficient <Deff>;  (1B) Plot of  particle diameter of the 
polyelectrolyte NPs, the PEG-PLGA and the capsid virus AD5 versus Effective Diffusion 
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Coefficient <Deff>;  (1C) Plot of zeta potential of the polyelectrolyte NPs versus Effective 
Diffusion Coefficient <Deff>; (1D) Plot of  zeta potential of the polyelectrolyte NPs, the 
PEG-PLGA and the capsid virus AD5 versus Effective Diffusion Coefficient <Deff>;  (1E) 
Plot of zeta potential of the polyelectrolyte NPs versus %ratio [Deff]/[D°], a measure of the  
efficiency of  a particle‟s  diffusion in mucus compared to its diffusion in water;  (1F) Plot of  
zeta potential of the polyelectrolyte NPs, the  PEG-PLGA and the capsid virus AD5 versus  
%ratio [Deff]/[D°].  Particle diameter is expressed in nm, zeta potential is expressed in mV 
and <Deff> is expressed in cm2. s-1 x10-9. 
Figure 2: Three-dimensional response analysis  showing the multi-variate relationship 
between particle diameter and zeta potential to polyelectrolyte particle diffusion 
kinetics in mucus.  The polyelectrolyte particles were formed by self-assembly of various 
ratios of PAA and chitosan.  Particle diameter is expressed in nm, zeta potential is expressed 
in mV and the Effective Diffusion Coefficient <Deff> is expressed in cm2. s-1 x10-9.  
Figure 3: Heterogeneity of particle movement through mucus.  For each particle type an 
effective diffusion coefficient (Deff) was calculated for each of 360 individual particles over 
a time interval of 1 sec. The data was ranked into percentiles from the 90th through to 10th 
percentile, where the 90th percentile is the Deff value below which 90% of the Deff 
observations may be found. (3A) data for the negatively charged [F1] polyelectrolyte 
formulation; (3B) data for the positively charged [F14] polyelectrolyte formulation; (3C) data 
for the neutrally charged [F8] polyelectrolyte formulation; (3D) data for the PEG-PLGA 
particle. Figure presents data of from three separate experiments, i.e. ≥ 360 individual 
particles examined for each particle type. 
Supplementary Figure 1:  Rheology of the mucus model.  Strain sweep test of mucus in 
the % strain range of 12 to 95 at which the viscoelastic plateau curve was obtained with the 
phase angle δ remaining constant.  The storage modulus G′ values were higher the loss 
modulus values G′′ at all the % strain tested values. The mucus was freshly isolated from pig 
intestinal ileum by gently scraping the intestinal surface to optimise the yield of not only the 
loose mucus layer but critically also a high content of the adherent mucus layer.    
Supplementary Figure 2: AFM imaging of the mucus model.  (S2A) AFM surface 
morphology of the mucus with large (25x25 µm), medium (15x15 µm) and  small (5x5 µm) 
field images of  the network of pores;  (S2B)  size distribution of over 98% of all visible 
pores within the mucus gel across ten randomly selected AFM fields each of 25x25 µm. 
Supplementary Figure 3: Illustrative profile of the Effective Diffusion Coefficients 
(Deff) for each of 20 randomly individual particles. The profiles show 20 particles from 
formulation [F8] across the time intervals of 1 sec.  and 0.2 sec. Some particles display a rise 
in Deff across the 1 sec. interval indicative of diffusive transport; those particles that display 
such an increase represent the proportion of diffusive particles.  The online source 
random.org was used to randomly select the particles. 
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Supplementary Video 1: Video capture (x63 magnification oil immersion lens) across 300 
frames (10 seconds) of the diffusive movements in intestinal porcine mucus of the 334 nm 
diameter polyelectrolyte neutral particles, i.e.  [F8] formulation.  
Supplementary Video 2: Video capture (x63 magnification oil immersion lens) across 300 
frames (10 seconds) of the diffusive movements in intestinal porcine mucus of the 54 nm 
PEG-PLGA particles.  
Supplementary Video 3: Video capture (x63 magnification oil immersion lens) across 300 
frames (10 seconds) of the diffusive movements in intestinal porcine mucus of the 146 nm 
AD5 capsid virus.   
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Table 1  Particle physical characteristics and diffusion kinetics in mucus.
Nature of  NPs PAA:Chitosan 
Mass ratio 
Code Zeta Potential 
(mV) 
Mean (± s.d.) 
Particle 
Diameter   
(nm) 
Mean (PDI) 
D°  (water) 
cm2. S-1 x10-9 
<Deff>  (mucus) 
cm2. S-1 x10-9
Mean (± s.e.m) 
% Ratio 
<Deff> / 
D° 
% 
Diffusive 
particles 
Negatively 
charged  
Polyelectrolyte 
5:1 F1 -29.1 (±3.6) 104 (0.14) 43.21 0.00163 (±0.00031) 0.0038 1 
4:1 F2 -30.6 (±4.4) 149 (0.10) 30.16 0.00366 (±0.00067) 0.0121 2 
3:1 F3 -25.0 (±4.0) 204 (0.21) 22.03 0.01781 (±0.00378) 0.0809 6 
2:1 F4 -18.9 (±1.3) 225 (0.13) 19.97 0.01574 (±0.00329) 0.0788 4 
1:1 F5 -15.4 (±0.8) 357 (0.21) 12.59 0.02286 (±0.00534) 0.1816 5 
1:1* F6 -15.2 (±1.2) 365 (0.21) 12.31 0.01749 (±0.00365) 0.1421 - 
Neutral  
Polyelectrolyte 
1:2.2 F7 -0.5 (±1.9)  1244 (0.32)  3.61 0.00239 (±0.00064) 0.0661 1 
1:2.2* F8 +1.1 (±2.4) 334 (0.19) 13.46 0.02887 (±0.00501) 0.2146 13 
Positively 
charged  
Polyelectrolyte 
1:3 F9 +6.0 (±1.1) 144 (0.18) 31.21 0.03182 (±0.00650) 0.1019 9 
1:4 F10 +14.3 (±0.3) 104 (0.09) 43.21 0.00849 (±0.00213) 0.0196 2 
1:5 F11 +19.2 (±0.5) 180 (0.17) 24.97 0.00104 (±0.00018) 0.0042 1 
1:6 F12 +19.5 (±0.9) 293 (0.17) 15.34 0.00084 (±0.00014) 0.0055 1 
1:8 F13 +19.2 (±0.6) 359 (0.11) 12.52 0.00031 (±0.00009) 0.0024 1 
1:8* F14 +19.5 (±2.3) 373 (0.23) 11.92 0.00032 (±0.00006) 0.0030 - 
Lipophilic PLGA - -29.2 (±2.1) 161 (0.03) 27.91 0.00013 (±0.00002) 0.0005 1 
Hydrophillic PEG-PLGA - -8.3 (±1.2)  54 (0.03) 83.22 0.46889 (±0.09343) 0.5634 32 
Capsid Virus AD5 - -0.5 (±2.3) 146 (0.18) 30.78 0.04391 (±0.00891) 0.1426 19 
* indicates NPs sonicated after fabrication prior to diffusion measurement.
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ABBREVIATIONS 
AD5  Adenovirus mV Millivolt 
AFM  Atomic force microscopy nm Nanometer 
D°     Absolute diffusion NP(s) Nanoparticle(s) 
Deff Effective diffusion coefficient PAA Polyacrylic acid 
<Deff> Ensemble effective diffusion 
coefficient  
PAM Polyallylamine 
DF Diffusivity factor PBS Phosphate buffer saline 
G´  Storage modulus PDI Poly Dispersity Index 
G´´ Loss modulus PEC NPs Polyelectrolyte Nanoparticles 
GIT   Gastrointestinal tract PEG-NP PEGylated nanoparticles 
IEP Isoelectric point PLGA Poly(lactic-co-glycolic acid) 
K Boltzmann constant r Radius of Nanoparticles 
KHz Kilo hertz SD Square Displacement 
LR Lumogen Red 305 s.d. Standard deviation 
MPT Multiple particle tracking Sec Second 
MSD Mean square displacement s.e.m Standard error of mean 
<MSD> Ensemble mean square 
displacement 
 t Time interval 
η Water viscosity T Absolute temperature 
µm Micrometre δ Phase angle 
+ve Positive charge -ve Negative charge  
Abbreviations
